Stability of chitosan-pDNA complex powder prepared by supercritical carbon dioxide process

被引:42
作者
Okamoto, H [1 ]
Sakakura, Y [1 ]
Shiraki, K [1 ]
Oka, K [1 ]
Nishida, S [1 ]
Todo, H [1 ]
Iida, K [1 ]
Danjo, K [1 ]
机构
[1] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan
关键词
plasmid DNA; chitosan; supercritical carbon dioxide; dry powder; gene delivery system; stability;
D O I
10.1016/j.ijpharm.2004.11.026
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The present study examined the stability of a gene in powders prepared with supercritical carbon dioxide (CO2) from the viewpoints of the ternary structure of DNA and in vivo transfection potential. An aqueous chitosan-pCMV-Luc complex solution containing mannitol was injected into the stream of a supercritical CO2/ethanol admixture to precipitate a gene powder. The obtained gene powders and gene solutions were placed in stability chambers at 25 or 40 degreesC for 4 weeks. The integrity and transfection potency of the gene were examined by electrophoresis and in vivo pulmonary transfection study in mice. The supercritical CO2 process decreased the supercoiled DNA during the manufacturing process; however, the decrease in the remaining supercoiled and open circular DNA in the powders during storage was much slower than that in solutions. In addition, the powders had higher transfection potency than the solutions containing the same amount of DNA. The effect of chitosan on the stability of DNA in solutions was not obvious in the solutions but it improved the stability of DNA in powders during manufacturing and storage. Thus, a gene powder with a cationic vector is a promising ready-to-use formulation for inhalation therapy of pulmonary diseases. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 31 条
  • [11] The influence of sodium glycocholate and other additives on the in vivo transfection of plasmid DNA in the lungs
    Freeman, DJ
    Niven, RW
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (02) : 202 - 209
  • [12] Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS)
    Ghaderi, R
    Artursson, P
    Carlfors, J
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (05) : 676 - 681
  • [13] Poly(ethylenimine) and its role in gene delivery
    Godbey, WT
    Wu, KK
    Mikos, AG
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) : 149 - 160
  • [14] Studies on electrotransfer of DNA into Escherichia coli: Effect of molecular form of DNA
    Kimoto, H
    Taketo, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1996, 1307 (03): : 325 - 330
  • [15] Preparation of chitosan self-aggregates as a gene delivery system
    Lee, KY
    Kwon, IC
    Kim, YH
    Jo, WH
    Jeong, SY
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 51 (2-3) : 213 - 220
  • [16] Li B, 2000, J PHARM SCI-US, V89, P355, DOI 10.1002/(SICI)1520-6017(200003)89:3<355::AID-JPS7>3.0.CO
  • [17] 2-H
  • [18] EFFECT OF DIFFERENT MODES OF INHALATION ON DRUG-DELIVERY FROM A DRY POWDER INHALER
    NEWMAN, SP
    HOLLINGWORTH, A
    CLARK, AR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 102 (1-3) : 127 - 132
  • [19] Biodistribution of radiolabeled lipid - DNA complexes and DNA in mice
    Niven, R
    Pearlman, R
    Wedeking, T
    Mackeigan, J
    Noker, P
    Simpson-Herren, L
    Smith, JG
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (11) : 1292 - 1299
  • [20] Pulmonary gene delivery by chitosan-pDNA complex powder prepared by a supercritical carbon dioxide process
    Okamoto, H
    Nishida, S
    Todo, H
    Sakakura, Y
    Iida, K
    Danjo, K
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (02) : 371 - 380